Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1099.4000 25.35 (2.36%)
NSE Apr 02, 2025 12:10 PM
Volume: 118.4K
 

1099.40
2.36%
Geojit BNP Paribas
We downgrade our rating from Buy to Accumulate, based on 22x FY22E EPS with a target price of Rs.746 as the recent rally has factored in the positive triggers for the company . SPL's Q1FY21 revenue grew by 21% YoY to Rs.238cr led by growth...
Suven Pharmaceutical.. has an average target of 1402.50 from 2 brokers.
More from Suven Pharmaceuticals Ltd.
Recommended